Secondly, our results, that stem cell-mediated invasion depends on aberrant induction of drugable targets, such as mTOR, HIF-1α or MMPs, might open a new window of opportunity to minimise the therapy-associated tumour risk. This evidence concerns the gene HIF1A and neoplasm.